Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
-
eventOn November 2, 2023, PhRMA’s Dr. Michael Ybarra was invited to speak on the panel, “Innovation, Funding and Access to Orphan Drugs: Challenges and Opportunities” at the 2023 North America Rare Disease Summit. During the panel participants examined the current state of rare disease research and the policy solutions needed to advance rare disease treatment. Dr. Ybarra emphasized the harm that the Inflation Reduction Act poses to biopharmaceutical innovation, forcing the industry to rethink its crucial R&D investments, ultimately delaying groundbreaking innovations for patients living with rare diseases.
November 2, 2023
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.